Arvind Kumar Sharma

Arvind Kumar Sharma

Director Director DIN 07020141
DIN 07020141 First appointment Jan 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2015
Shareholding value •••• Premium profile

About Arvind Kumar Sharma

Data last updated:

Arvind Kumar Sharma was a Director at Meyonex Pharmaceuticals Limited (2015–2020) and Director at Westfin International Private Limited (2019–2020). The companies operate in Pharma.

DIN 07020141
Primary Designation Director
Industry Pharma
First Appointment 17 Jan 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meyonex Pharmaceuticals Limited U74120MH2015PLC261024
Director17 Jan 20152015₹108 Cr (FY 2025)Active
Director29 Jan 20192019₹27.16 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meyonex Pharmaceuticals Limited
Westfin International Private Limited
Premium access

Shareholding and investment profile for Arvind Kumar Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Kumar Sharma

Arvind Kumar Sharma was first appointed on 17 Jan 2015 as Director at Meyonex Pharmaceuticals Limited. The most recent appointment on record is 29 Jan 2019 at Westfin International Private Limited.

Arvind Kumar Sharma held 2 earlier board appointments: Meyonex Pharmaceuticals Limited (Director, 17 Jan 2015 to 13 Aug 2020); Westfin International Private Limited (Director, 29 Jan 2019 to 20 Aug 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available